IHS Chemical Week

World News and Views :: Top of the News

Novozymes acquires enzyme business from Iogen

12:01 AM MST | February 1, 2013 | Deepti Ramesh

Novozymes says it will acquire Iogen Bio-Products, the industrial enzyme business of Iogen (Ottawa, ON) for C$67.5 million ($67.6 million) and potential earn-out payments of up to C$12.5 million. The deal provides Novozymes with all commercial rights to Iogen Bio-Products’ existing product portfolio, pipeline, facilities, and know-how. The acquisition does not include the purchase of process technology assets that relate to Iogen’s second-generation biofuels business. The acquisition is expected to be completed by the end of this month. Iogen...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa